Trends in the Dispensing and Costs of Glucose-Lowering Medications Among Older Australians: Findings from National Claims Data
ConclusionsThe treatment landscape for diabetes in Australia is undergoing dynamic change. More patients were initiated with the newer but costlier GLD over the study period.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Australia Health | Diabetes | Endocrinology | Fortamet | Geriatrics | Metformin | Sodium | Study